Oramed Pharmaceuticals won approval to run an initial clinical trial for its orally delivered Covid-19 vaccine candidate in South Africa. “Oravax’s oral Covid-19 vaccine candidate could offer an exciting potential solution to the Covid pandemic and would eliminate several barriers to rapid, wide-scale distribution, potentially enabling people to administer the vaccine themselves at home,” said Oramed CEO Nadav Kidron. Read more here.
